Clark Henegan (@clarkhenegan) 's Twitter Profile
Clark Henegan

@clarkhenegan

Medical Oncologist with focus in prostate, bladder, kidney and testicular cancers. Tweets reflect my personal opinion.

ID: 1124733403851644929

calendar_today04-05-2019 17:51:54

782 Tweet

366 Takipçi

505 Takip Edilen

UMMC Cancer Center and Research Institute (@ummc_cancer) 's Twitter Profile Photo

Congratulations to Sharon Ezell, nurse practitioner in the Department of Radiation Oncology, for earning two prestigious oncology certifications—Oncology Certified Nurse and Advanced Oncology Certified Nurse Practitioner! Read more: umc.edu/cancerinstitut…

Congratulations to Sharon Ezell, nurse practitioner in the Department of Radiation Oncology, for earning two prestigious oncology certifications—Oncology Certified Nurse and Advanced Oncology Certified Nurse Practitioner! 

Read more: umc.edu/cancerinstitut…
Clark Henegan (@clarkhenegan) 's Twitter Profile Photo

Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variant. Longitudinal outcome analysis indicates that patients w this variant may have favorable responses to AR targeting therapy nature.com/articles/s4139…

UMMC Cancer Center and Research Institute (@ummc_cancer) 's Twitter Profile Photo

Survivor University provides resources to improve the quality of life of individuals facing cancer. In a recent expansion, the program is now open to all Mississippians, not just those treated at the University of Mississippi Medical Center. umc.edu/cancerinstitut… Rod Rocconi

Survivor University provides resources to improve the quality of life of individuals facing cancer. In a recent expansion, the program is now open to all Mississippians, not just those treated at the University of Mississippi Medical Center. umc.edu/cancerinstitut… <a href="/rodrocconi/">Rod Rocconi</a>
Devika Das, MD, MSHQS (@devikadasmd) 's Twitter Profile Photo

Honored to announce that I’ve accepted the role of Division Director of Hem/Onc and Associate Director for Clinical Affairs at the Cancer Center, University of Mississippi! Looking forward to contributing to the team’s growth and success this fall! #lcsm UMMC Cancer Center and Research Institute Rod Rocconi

Ian Davis (@prof_iand) 's Twitter Profile Photo

Two opinions that to my surprise are either unpopular or not widely held: 1. The control arm of a randomised trial should be best standard of care. 2. A PFS benefit against an inactive comparator is not a major advance, if progressive disease is required for eligibility.

UMMC Cancer Center and Research Institute (@ummc_cancer) 's Twitter Profile Photo

The Cancer Center and Research Institite recently hosted a community health education fair in Lexington, Mississippi, where Dr. Justin Turner spoke about cancer health in our state. Participants visited vendors and learned about resources to assist with their needs. Rod Rocconi

The Cancer Center and Research Institite recently hosted a community health education fair in Lexington, Mississippi, where Dr. Justin Turner spoke about cancer health in our state. Participants visited vendors and learned about resources to assist with their needs. <a href="/rodrocconi/">Rod Rocconi</a>
UMMC Department of Medicine (@ummcmedicine) 's Twitter Profile Photo

Department of Medicine Grand Rounds Tuesday, September 9th at noon, Dr. Rod Rocconi will present "OVARCOMING Ovarian Cancer with Immunotherapy" in R354 and WebEx umc.webex.com/umc/j.php?MTID…

Department of Medicine Grand Rounds Tuesday, September 9th at noon, Dr. Rod Rocconi will present "OVARCOMING Ovarian Cancer with Immunotherapy" in R354 and WebEx umc.webex.com/umc/j.php?MTID…
Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo

🚨Just in Nature Medicine 👉 results from the Ph 3 AMPLITUDE trial: adding niraparib to abiraterone ⬆️outcomes in HRR-altered mHSPC #prostatecancer 👉 RPFS ⬆️: BRCA 1/2 HR 0.52, P < 0.0001; ITT HR 0.63, P =0.0001 Open link👉 bit.ly/47lt5Oj Prostate Cancer Foundation OncoAlert UroToday.com

🚨Just in <a href="/NatureMedicine/">Nature Medicine</a> 👉 results from the Ph 3 AMPLITUDE trial: adding niraparib to abiraterone ⬆️outcomes in HRR-altered mHSPC #prostatecancer 👉 RPFS ⬆️: BRCA 1/2 HR 0.52, P &lt; 0.0001; ITT HR 0.63, P =0.0001 Open link👉 bit.ly/47lt5Oj <a href="/PCFnews/">Prostate Cancer Foundation</a> <a href="/OncoAlert/">OncoAlert</a> <a href="/urotoday/">UroToday.com</a>
Toni Choueiri, MD (@drchoueiri) 's Twitter Profile Photo

Field-moving data , a new-era, with #Christofvulsteke in cisplatin-ineligible MIBC. KEYNOTE-905, Ph.III, finds periop EV+pembro smashing risk (EFS HR 0.40), improving survival (OS HR 0.50), and quadrupling pCR to 57% vs 9%. #ESMO25 #BladderCancer ESMO - Eur. Oncology Annals of Oncology

Field-moving data , a new-era, with #Christofvulsteke in cisplatin-ineligible MIBC. 
KEYNOTE-905, Ph.III, finds periop EV+pembro smashing risk (EFS HR 0.40), improving survival (OS HR 0.50), and quadrupling pCR to 57% vs 9%.
#ESMO25 #BladderCancer <a href="/myESMO/">ESMO - Eur. Oncology</a> <a href="/Annals_Oncology/">Annals of Oncology</a>
UMMC Cancer Center and Research Institute (@ummc_cancer) 's Twitter Profile Photo

UMMC experts are transforming cancer treatment through programs like Survivor University and Lifestyle Medicine Cancer Care — helping patients live well during and after treatment. Learn more: umc.edu/news/News_Arti…

UMMC experts are transforming cancer treatment through programs like Survivor University and Lifestyle Medicine Cancer Care — helping patients live well during and after treatment. Learn more: umc.edu/news/News_Arti…
UMMC Cancer Center and Research Institute (@ummc_cancer) 's Twitter Profile Photo

Thanks, Dr. Justin Turner, for sharing the news about CCRI programs such as Survivor University! You can learn more about this and other resources at the Stronger Together Health Fair Nov. 15 in Jackson. RSVP at bit.ly/492g3aJ Watch the video: bit.ly/49PAecc

Thanks, Dr. Justin Turner, for sharing the news about CCRI programs such as Survivor University! You can learn more about this and other resources at the Stronger Together Health Fair Nov. 15 in Jackson. 
RSVP at bit.ly/492g3aJ
Watch the video: bit.ly/49PAecc
UMMC Academic Affairs (@ummcacademics) 's Twitter Profile Photo

📣ANNOUNCING The Nelson Order for Teaching Excellence Inductees for 2025-2026 Congratulations, Amanda V. Clark, MD, and Samuel D. Dickinson, DNP, APRN, PMHNP-BC!

📣ANNOUNCING The Nelson Order for Teaching Excellence Inductees for 2025-2026

Congratulations, Amanda V. Clark, MD, and Samuel D. Dickinson, DNP, APRN, PMHNP-BC!
The University of Mississippi Medical Center (@ummcnews) 's Twitter Profile Photo

UMMC has reached $100M toward its $125M goal for a new Cancer Center and Research Institute, launching the public phase of the campaign. Read more: umc.edu/news/News_Arti…

UMMC has reached $100M toward its $125M goal for a new Cancer Center and Research Institute, launching the public phase of the campaign. Read more: umc.edu/news/News_Arti…
Rod Rocconi (@rodrocconi) 's Twitter Profile Photo

Didn’t miss it…. But you can post it as many times as you like 😎. Aiming to create #AHealthierMississippi #ONEmississippi #cancercareintheSIP

UMMC Cancer Center and Research Institute (@ummc_cancer) 's Twitter Profile Photo

Today we’re spotlighting Dr. Muhammad Hassan, assistant professor of pathology and breast pathology specialist at UMMC and a valued CCRI team member. Since 2021, he’s interpreted 2,300+ specimens for breast cancer care.

Today we’re spotlighting Dr. Muhammad Hassan, assistant professor of pathology and breast pathology specialist at UMMC and a valued CCRI team member. Since 2021, he’s interpreted 2,300+ specimens for breast cancer care.